References
- Weatherall DJ. The thalassaemias. BMJ. 1997;314(7095):1675–1678.
- Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775–a011775.
- Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of α and β thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol. 2004;57(5):517–522.
- Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010;78(2):139–148.
- Zhang J, Zhu BS, He J, et al. The spectrum of α- and β-thalassemia mutations in Yunnan Province of Southwestern China. Hemoglobin. 2012;36(5):464–473.
- Yao H, Chen X, Lin L, et al. The spectrum of α- and β-thalassemia mutations of the Li people in Hainan Province of China. Blood Cells Mol Dis. 2014;53(1–2):16–20.
- Xu X, Wu X. Epidemiology and treatment of β thalassemia major in China. Pediatr Invest. 2020;4(1):43–47.
- Bhardwaj U, McCabe ER. Multiplex-PCR assay for the deletions causing hereditary persistence of fetal hemoglobin. Mol Diagn. 2005;9(3):151–156.
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucl Acids Res. 2014;42(D1):D1063–D1069 (https://globin.bx.psu.edu/hbvar/menu/html/).
- Fallah MS, Mahdian R, Aleyasin S-A, et al. Development of a quantitative real-time PCR assay for detection of unknown alpha-globin gene deletions. Blood Cells Mol Dis. 2010;45(1):58–64.
- He J, Song W, Yang J, et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017;19(9):1022–1031.
- Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020.
- Richards S, Aziz N, Bale S, et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424.
- Jiang F, Ju AP, Li J, et al. Hb Westmead (HBA2: c.369C>G): hematological characteristics in heterozygotes with and without α0-thalassemia. Hemoglobin. 2020;44(3):153–155.
- Peng Q, Zhang Z, Li S, et al. Molecular epidemiological and hematological profile of thalassemia in the Dongguan Region of Guangdong Province, Southern China. J Clin Lab Anal. 2021;35(2):e23596.
- Fang J, Chen L, Zeng R, et al. The Hb H disease genotypes in southern China. Hemoglobin. 2014;38(1):76–78.
- Fei YJ, Stoming TA, Kutlar A, et al. One form of inclusion body beta-thalassemia is due to a GAA----TAA mutation at codon 121 of the beta chain. Blood. 1989;73(4):1075–1077.
- Thein SL, Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body beta-thalassemia. Proc Natl Acad Sci USA. 1990;87(10):3924–3298.
- Yamamoto K, Yamamoto K, Hattori Y, et al. Two β-thalassemia mutations in Japan: codon 121 (GAA→TAA) and IVS-I-130 (G→C). Hemoglobin. 1992;16(4):295–302.
- Vetter B, Neu-Yilik G, Kohne E, et al. Dominant beta-thalassaemia: a highly unstable haemoglobin is caused by a novel 6 bp deletion of the beta-globin gene. Br J Haematol. 2000;108(1):176–181.
- Cao A, Galanello R, Rosatelli MC. Genotype-phenotype correlations in beta-thalassemias. Blood Rev. 1994;8(1):1–12.
- Henderson SJ, Timbs AT, McCarthy J, et al. Ten years of routine α-and β-globin gene sequencing in UK hemoglobinopathy referrals reveals 60 novel mutations. Hemoglobin. 2016;40(2):75–84.